Page last updated: 2024-08-26

cv 6504 and Cancer of Pancreas

cv 6504 has been researched along with Cancer of Pancreas in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, DA; Baddeley, J; Bramhall, S; Buckels, J; Daryanani, S; Deakin, M; Doran, J; Ferry, DR; Kerr, DJ; Pemberton, G; Wakelam, MJ; Young, AM	1

Trials

1 trial(s) available for cv 6504 and Cancer of Pancreas

Article	Year
A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:9 Topics: Antineoplastic Agents; Benzoquinones; Disease Progression; Disease-Free Survival; Drug Evaluation; Female; Humans; Linoleic Acid; Lipoxygenase Inhibitors; Male; Middle Aged; Pancreatic Neoplasms; Thromboxane B2	2000

Article

Year

A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints.

Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:9

Topics: Antineoplastic Agents; Benzoquinones; Disease Progression; Disease-Free Survival; Drug Evaluation; Female; Humans; Linoleic Acid; Lipoxygenase Inhibitors; Male; Middle Aged; Pancreatic Neoplasms; Thromboxane B2

2000